GlaxoSmithKline consumer business Haleon lays out game plan after July spinout
The world’s largest consumer healthcare business now has a business strategy to go along with its new name. Haleon, the recently announced brand name for GSK Consumer Healthcare when it’s spun out of GSK this summer, laid out its future in an official unveiling to investors on GSK’s capital markets day.
GSK CEO Emma Walmsley, along with Brian McNamara, the CEO of GSK Consumer Healthcare and incoming CEO at Haleon, talked up Haleon’s R&D pipeline, finances and the potential for future M&A deals.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.